PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,552,257 | +1373.0% | 309,640 | +1126.6% | 0.15% | +1272.7% |
| Q1 2023 | $580,589 | +33.0% | 25,243 | -36.9% | 0.01% | +57.1% |
| Q4 2022 | $436,400 | +29.5% | 40,000 | 0.0% | 0.01% | +40.0% |
| Q3 2022 | $337,000 | -93.3% | 40,000 | -93.7% | 0.01% | -92.9% |
| Q2 2022 | $5,055,000 | -67.9% | 639,100 | -4.0% | 0.07% | -63.2% |
| Q1 2022 | $15,770,000 | +4.0% | 666,000 | +50.3% | 0.19% | +11.8% |
| Q4 2021 | $15,157,000 | +46.2% | 443,202 | -24.2% | 0.17% | +44.1% |
| Q3 2021 | $10,365,000 | – | 585,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |